Artificial Superintelligence arrives by roughly 2030 — shortly thereafter all human illnesses will be cured 'much sooner than we think'; mechanism: AI not just predicting protein structures but generating novel biological designs revolutionizing drug d...

Artificial Superintelligence arrives by roughly 2030 — shortly thereafter all human illnesses will be cured 'much sooner than we think'; mechanism: AI not just predicting protein structures but generating novel biological designs revolutionizing drug discovery and personalized medicine. Human cybernetic augmentation and synthetic organ generation follow closely behind disease eradication. | First ASI-designation consensus event

Key catalyst: First ASI-designation consensus event

Watch events: Isomorphic Labs drug-approval milestones; ASI capability benchmarks

AlphaFold + Isomorphic Labs drug-design validate framework; ASI-by-2030 aggressive even for Hassabis cohort; "all illnesses cured" is maximalist framing.

Beneficiaries (12)

{
  "nia": false,
  "mode": "FORECAST",
  "role": "Cited-CEO",
  "context": "Fourth Hassabis entry (AUT_012 world models 2030-35, ROB_004 solve physics, ROB_005 physical intelligence AGI, CYB_019 world models). Sharpens 247_033 (cure all disease decade) with specific ASI-2030 + cybernetic-augmentation framing.",
  "to_year": 2040,
  "conv_cues": "CEO FIRST_PERSON; specific ASI timing + disease-cure sequencing",
  "direction": "HAPPEN",
  "from_year": 2030,
  "timeframe": "2030-2040",
  "conv_level": "HIGH",
  "milestones": [
    {
      "kind": "llm_pre_event",
      "label": "Major frontier lab (DeepMind, OpenAI, Anthropic, xAI) publicly claims AGI achievement with ARC-AGI / GAIA / SWE-bench Verified scores at human expert level",
      "source": "https://evolutionaihub.com/google-deepmind-secret-plan-2030-demis-hassabis/",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -9,
      "source_id": null,
      "confidence": 0.55,
      "source_url": "https://evolutionaihub.com/google-deepmind-secret-plan-2030-demis-hassabis/",
      "expected_date": "2028-12-31",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2030-12-31",
        "from": "2027-01-01"
      },
      "measurement_criterion": "DeepMind / OpenAI / Anthropic public benchmark report or peer-reviewed paper where their model scores at or above human-expert level on widely-recognized AGI proxies (ARC-AGI, GAIA, SWE-bench Verified-multi-day, OSWorld) — Hassabis 2030 AGI prediction checkpoint"
    },
    {
      "kind": "llm_pre_event",
      "label": "Cumulative AI-discovered drug pipeline crosses 100 active clinical-stage programs across major AI biotech firms",
      "source": "https://opentools.ai/news/deepminds-bold-prediction-could-ai-eradicate-all-diseases-in-a-decade",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -8,
      "source_id": null,
      "confidence": 0.6,
      "source_url": "https://opentools.ai/news/deepminds-bold-prediction-could-ai-eradicate-all-diseases-in-a-decade",
      "expected_date": "2029-09-15",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2031-12-31",
        "from": "2027-06-01"
      },
      "measurement_criterion": "Aggregate count from Isomorphic, Recursion, Insitro, Insilico, Schrödinger, BenevolentAI, Exscientia of active Phase 1+ clinical programs derived from AI-led discovery exceeds 100 (vs. <30 today), per ClinicalTrials.gov registry queries and industry tracker (Endpoints, BiopharmaTrend)"
    },
    {
      "kind": "llm_pre_event",
      "label": "First AI-discovered cure for previously incurable rare disease gains FDA Breakthrough Therapy designation",
      "source": "https://theindianpractitioner.com/demis-hassabis-predicts-end-of-all-disease-within-a-decade/",
      "status": "pending",
      "weight": 0.4,
      "ordinal": -7,
      "source_id": null,
      "confidence": 0.55,
      "source_url": "https://theindianpractitioner.com/demis-hassabis-predicts-end-of-all-disease-within-a-decade/",
      "expected_date": "2030-12-31",
      "research_origin": "deep_research",
      "expected_date_range": {
        "to": "2033-12-31",
        "from": "2028-01-01"
      },
      "measurement_criterion": "FDA Breakthrough Therapy designation for therapeutic where lead candidate was AI-discovered (Isomorphic, Recursion, Insitro, Insilico, or successor) for an indication previously categorized as having no curative treatment"
    },
    {
      "kind": "quartile_checkpoint",
      "label": "Q1 window check-in (25%)",
      "status": "pending",
      "weight": 0.05,
      "ordinal": -6,
      "source_id": null,
      "expected_date": "2031-12-27",
      "observed_date": null
    },
    {
      "kind": "llm_pre_event",
      "label": "Drug discovery cycle time benchmark drops from ~10 years to under 4 years for AI-led programs (industry-wide median)",
      "source": "https://bmmagazine.co.uk/tech/deepmind-chief-predict
... (truncated)